Vaccine Against Schistosomiasis for Africa (VASA) project consortium held an annual General Assembly Meeting on 27 January 2022. On a yearly basis, members from the VASA project consortium are gathered to exchange the achievements and current status of ongoing Work Packages including the clinical trials, sero-epidemiology studies, health economics studies, and human challenge trial, as…
UCAM-IVI 1st pre-site assessment visit in Ouagadougou, Burkina Faso was conducted on 26-29 November 2019. During the visit, a group of members from the University of Cambridge and International Vaccine Institute visited the Groupe de Recherche Action en Santé (GRAS) and University of Ouagadougou for discussing the Phase I clinical trial and sero-epidemiology study.
On 24-25 July 2019, the official VASA project kick-off meeting took place in Paris, France. A representative from each consortium partners attended the meeting for officially initiating the project, and various discussion on discussing a direction of the project was held for a successful execution and completion of the project.
ㅤMedia and Publication
This Project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement (No.815643)